Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06407024 · ClinicalTrials.gov registry record · NA
Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy
A NA study of Adrenalectomy, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT06407024: Recruiting NA study of Adrenalectomy, sponsored by The Cleveland Clinic.
NCT06407024 is a NA study of Adrenalectomy that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06407024, a NA study of Adrenalectomy, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care. The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures. The information from this study will help improve patient care, patient outcomes and maximize the appropriate utilization of resources in adrenal surgery.
Primary Outcome
The duration of the procedure measured in hours and/or minutes
Conditions Studied
Interventions
- PROCEDURE laparoscopic transabdominal adrenalectomy
- PROCEDURE robotic transabdominal adrenalectomy
Study Locations (1)
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06407024 shows while recruiting
NCT06407024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Adrenalectomy appearing as the primary indexed condition, and to 2 interventions - of which laparoscopic transabdominal adrenalectomy is the first listed.
NCT06407024 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06407024 about?
NCT06407024 is a clinical study titled "Laparoscopic Versus Robotic Lateral Transabdominal Adrenalectomy". This study is being done to compare Laparoscopic vs Robotic lateral transabdominal adrenalectomy, these procedures are both standard of care. The study team would like to compare both patient outcomes and surgeon efficiency and perspectives among both procedures. The information from this study wi...
What is the current status of trial NCT06407024?
This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2024-05-22. Estimated completion is 2026-12-31.
What conditions does trial NCT06407024 study?
This clinical trial studies the following conditions: Adrenalectomy.
What interventions are being tested in trial NCT06407024?
The interventions under investigation include: laparoscopic transabdominal adrenalectomy (PROCEDURE), robotic transabdominal adrenalectomy (PROCEDURE).
Who is sponsoring clinical trial NCT06407024?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06407024 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06407024's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI